Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)
China · Delayed Price · Currency is CNY 1.490
+0.070 (4.93%)
Jul 3, 2026, 3:04 PM CST
SHE:000078 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 25,182 | 26,612 | 30,214 | 36,310 | 37,759 | 40,926 |
Other Revenue | 55.39 | 55.39 | 102.93 | 108.77 | 76.08 | 127.23 |
| 25,237 | 26,668 | 30,317 | 36,419 | 37,835 | 41,054 | |
Revenue Growth (YoY) | -14.75% | -12.04% | -16.75% | -3.74% | -7.84% | 2.58% |
Cost of Revenue | 22,898 | 24,199 | 27,486 | 32,901 | 34,059 | 36,660 |
Gross Profit | 2,339 | 2,469 | 2,832 | 3,518 | 3,776 | 4,394 |
Selling, General & Admin | 1,734 | 1,808 | 2,243 | 2,540 | 2,680 | 2,709 |
Research & Development | 32.4 | 33.71 | 37.89 | 47.79 | 48.29 | 39.19 |
Other Operating Expenses | 76.41 | 74.41 | 94.58 | 103.65 | 102.17 | 114.22 |
Operating Expenses | 2,045 | 2,214 | 2,655 | 2,899 | 3,011 | 2,934 |
Operating Income | 294.6 | 254.72 | 176.9 | 618.73 | 764.95 | 1,460 |
Interest Expense | -627.11 | -624.77 | -808.77 | -945.94 | -930.86 | -875.54 |
Interest & Investment Income | - | 52.63 | 55.74 | 48.79 | 65.47 | 131.55 |
Currency Exchange Gain (Loss) | -0 | -0 | 0 | 0 | 0 | -1.64 |
Other Non Operating Income (Expenses) | -88.86 | -89.54 | -55.43 | -262.09 | -192.05 | -36.75 |
EBT Excluding Unusual Items | -421.37 | -406.96 | -631.57 | -540.51 | -292.48 | 677.31 |
Impairment of Goodwill | -137.29 | -137.29 | -477.78 | -875.96 | -523.77 | -183.67 |
Gain (Loss) on Sale of Investments | -8.82 | 12 | 6.38 | -27.67 | -86.66 | 37.71 |
Gain (Loss) on Sale of Assets | 1.21 | 4.86 | 6.81 | 3.24 | 11.33 | 0.22 |
Asset Writedown | -9.86 | -0.76 | - | -51.43 | -12.66 | -9.59 |
Other Unusual Items | 32.15 | 28.86 | 14.46 | 33.86 | 51.08 | 54.32 |
Pretax Income | -543.98 | -499.3 | -1,082 | -1,458 | -853.16 | 576.31 |
Income Tax Expense | 36.46 | 53.26 | 85.62 | 260.56 | 138.29 | 318.44 |
Earnings From Continuing Operations | -580.44 | -552.56 | -1,167 | -1,719 | -991.45 | 257.87 |
Minority Interest in Earnings | 8.16 | -10.5 | -26.1 | 29.09 | -35.52 | -164.57 |
Net Income | -572.28 | -563.06 | -1,193 | -1,690 | -1,027 | 93.3 |
Net Income to Common | -572.28 | -563.06 | -1,193 | -1,690 | -1,027 | 93.3 |
Shares Outstanding (Basic) | 2,631 | 2,631 | 2,631 | 2,631 | 2,630 | 2,628 |
Shares Outstanding (Diluted) | 2,631 | 2,631 | 2,631 | 2,631 | 2,630 | 2,628 |
Shares Change (YoY) | -0.02% | 0.01% | -0.00% | 0.05% | 0.07% | 0.19% |
EPS (Basic) | -0.22 | -0.21 | -0.45 | -0.64 | -0.39 | 0.04 |
EPS (Diluted) | -0.22 | -0.21 | -0.45 | -0.64 | -0.39 | 0.04 |
Free Cash Flow | -1.15 | -22.7 | -45.06 | -514.26 | -158.65 | 736.89 |
Free Cash Flow Per Share | - | -0.01 | -0.02 | -0.20 | -0.06 | 0.28 |
Gross Margin | 9.27% | 9.26% | 9.34% | 9.66% | 9.98% | 10.70% |
Operating Margin | 1.17% | 0.95% | 0.58% | 1.70% | 2.02% | 3.56% |
Profit Margin | -2.27% | -2.11% | -3.94% | -4.64% | -2.71% | 0.23% |
Free Cash Flow Margin | -0.01% | -0.08% | -0.15% | -1.41% | -0.42% | 1.80% |
EBITDA | 434.52 | 400.2 | 344.64 | 816.55 | 939.14 | 1,633 |
EBITDA Margin | 1.72% | 1.50% | 1.14% | 2.24% | 2.48% | 3.98% |
D&A For EBITDA | 139.92 | 145.49 | 167.75 | 197.82 | 174.19 | 172.97 |
EBIT | 294.6 | 254.72 | 176.9 | 618.73 | 764.95 | 1,460 |
EBIT Margin | 1.17% | 0.95% | 0.58% | 1.70% | 2.02% | 3.55% |
Effective Tax Rate | - | - | - | - | - | 55.25% |
Revenue as Reported | 25,237 | 26,668 | 30,317 | 36,419 | 37,835 | 41,054 |
Advertising Expenses | - | 12.64 | 10.74 | 25.17 | 41.15 | 77.05 |